197 related articles for article (PubMed ID: 15451463)
1. Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material.
Palmer DJ; Ng P
Mol Ther; 2004 Oct; 10(4):792-8. PubMed ID: 15451463
[TBL] [Abstract][Full Text] [Related]
2. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
[TBL] [Abstract][Full Text] [Related]
3. Identification of critical infection parameters to control helper-dependent adenoviral vector production.
Dormond E; Perrier M; Kamen A
J Biotechnol; 2009 Jun; 142(2):142-50. PubMed ID: 19501266
[TBL] [Abstract][Full Text] [Related]
4. Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus.
Leonard JN; Ferstl P; Delgado A; Schaffer DV
Biotechnol Bioeng; 2007 Aug; 97(5):1170-9. PubMed ID: 17252611
[TBL] [Abstract][Full Text] [Related]
5. Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions.
Meneses-Acosta A; Dormond E; Jacob D; Tom R; Bernier A; Perret S; St-Laurent G; Durocher Y; Gilbert R; Kamen A
J Virol Methods; 2008 Mar; 148(1-2):106-14. PubMed ID: 18079009
[TBL] [Abstract][Full Text] [Related]
6. Characterization of helper-dependent adenoviral vectors.
Palmer DJ; Ng P
Cold Spring Harb Protoc; 2011 Jul; 2011(7):867-70. PubMed ID: 21724820
[No Abstract] [Full Text] [Related]
7. Manufacturing of adenovirus vectors: production and purification of helper dependent adenovirus.
Dormond E; Kamen AA
Methods Mol Biol; 2011; 737():139-56. PubMed ID: 21590396
[TBL] [Abstract][Full Text] [Related]
8. Methods for the production of helper-dependent adenoviral vectors.
Palmer DJ; Ng P
Methods Mol Biol; 2008; 433():33-53. PubMed ID: 18679616
[TBL] [Abstract][Full Text] [Related]
9. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
10. Rescue, amplification, and large-scale production of helper-dependent adenoviral vectors.
Palmer DJ; Ng P
Cold Spring Harb Protoc; 2011 Jul; 2011(7):857-66. PubMed ID: 21724821
[No Abstract] [Full Text] [Related]
11. A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter.
Shi CX; Graham FL; Hitt MM
J Gene Med; 2006 Apr; 8(4):442-51. PubMed ID: 16389604
[TBL] [Abstract][Full Text] [Related]
12. Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.
Puntel M; Curtin JF; Zirger JM; Muhammad AK; Xiong W; Liu C; Hu J; Kroeger KM; Czer P; Sciascia S; Mondkar S; Lowenstein PR; Castro MG
Hum Gene Ther; 2006 May; 17(5):531-44. PubMed ID: 16716110
[TBL] [Abstract][Full Text] [Related]
13. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
[TBL] [Abstract][Full Text] [Related]
14. A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells.
Marzio G; Kerkvliet E; Bogaards JA; Koelewijn S; De Groot A; Gijsbers L; Weverling GJ; Vogels R; Havenga M; Custers J; Pau MG; Guichoux JY; Lewis J; Goudsmit J
Vaccine; 2007 Mar; 25(12):2228-37. PubMed ID: 17250936
[TBL] [Abstract][Full Text] [Related]
15. Replication and packaging of helper-dependent adenoviral vectors.
Sato M; Suzuki S; Kubo S; Mitani K
Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
[TBL] [Abstract][Full Text] [Related]
16. [Construction and preparation of helper-dependent adenoviral vector expressing human respiratory syncytial virus F gene].
Yang B; He JS; Shi CX; Zhang M; Yu JM
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):682-5. PubMed ID: 17944372
[TBL] [Abstract][Full Text] [Related]
17. Helper-dependent adenoviral vectors.
Oka K; Chan L
Curr Protoc Mol Biol; 2005 Feb; Chapter 16():Unit 16.24. PubMed ID: 18265354
[TBL] [Abstract][Full Text] [Related]
18. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR.
Zhang WW; Koch PE; Roth JA
Biotechniques; 1995 Mar; 18(3):444-7. PubMed ID: 7779393
[TBL] [Abstract][Full Text] [Related]
19. [In vitro transgenic expression efficacy of a helper-dependent adenoviral vector encoding enhanced green fluorescent protein].
Zheng X; He J; Fu Y; Xu S; Xie C; Shi C; Zhang M; Wang X; Hong T
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1108-15. PubMed ID: 21090116
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of an adenovirus production process.
Kamen A; Henry O
J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
